• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种高内涵AlphaScreen™技术鉴定出E6特异性小分子抑制剂可作为人乳头瘤病毒相关头颈部鳞状细胞癌的潜在治疗药物。

A high-content AlphaScreen™ identifies E6-specific small molecule inhibitors as potential therapeutics for HPV head and neck squamous cell carcinomas.

作者信息

Chitsike Lennox, Yuan Chung-Hsiang, Roy Anuradha, Boyle Kristopher, Duerksen-Hughes Penelope J

机构信息

Department of Basic Science, School of Medicine, Loma Linda University, Loma Linda, CA, USA.

High-Throughput Screening Laboratory, University of Kansas, Lawrence, KS, USA.

出版信息

Oncotarget. 2021 Mar 16;12(6):549-561. doi: 10.18632/oncotarget.27908.

DOI:10.18632/oncotarget.27908
PMID:33796223
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7984827/
Abstract

The incidence of human papillomavirus-positive head and neck squamous cell carcinoma (HPV-HNSCC) has increased dramatically over the past decades due to an increase in infection of the oral mucosa by HPV. The etiology of HPV-HNSCC is linked to expression of the HPV oncoprotein, E6, which influences tumor formation, growth and survival. E6 effects this oncogenic phenotype in part through inhibitory protein-protein interactions (PPIs) and accelerated degradation of proteins with tumor suppressor properties, such as p53 and caspase 8. Interfering with the binding between E6 and its cellular partners may therefore represent a reasonable pharmacological intervention in HPV tumors. In this study, we probed a small-molecule library using AlphaScreen™ technology to discover novel E6 inhibitors. Following a cascade of screens we identified and prioritized one hit compound. Structure activity relationship (SAR) studies of this lead uncovered an analog, 30-hydroxygambogic acid (GA-OH), that displayed improved activity. Further testing of this analog in a panel of HPV and HPV cell lines showed good potency and a large window of selectivity as demonstrated by apoptosis induction and significant inhibition of cell growth, cell survival in HPV cells. In summary, GA-OH may serve as a starting point for the development of potent E6-specific inhibitors.

摘要

在过去几十年中,由于人乳头瘤病毒(HPV)对口腔黏膜感染的增加,HPV阳性的头颈部鳞状细胞癌(HPV-HNSCC)的发病率急剧上升。HPV-HNSCC的病因与HPV致癌蛋白E6的表达有关,E6影响肿瘤的形成、生长和存活。E6部分通过抑制性蛋白质-蛋白质相互作用(PPI)以及加速具有肿瘤抑制特性的蛋白质(如p53和半胱天冬酶8)的降解来实现这种致癌表型。因此,干扰E6与其细胞伴侣之间的结合可能是对HPV肿瘤进行合理药物干预的一种方式。在本研究中,我们使用AlphaScreen™技术对一个小分子文库进行筛选,以发现新型E6抑制剂。经过一系列筛选,我们鉴定并确定了一个有活性的化合物。对该先导化合物的构效关系(SAR)研究发现了一种类似物,即30-羟基藤黄酸(GA-OH),其活性有所提高。在一组HPV和HPV细胞系中对该类似物进行的进一步测试显示出良好的效力和较大的选择性窗口,这通过凋亡诱导以及对HPV细胞中细胞生长和细胞存活的显著抑制得以证明。总之,GA-OH可能作为开发强效E6特异性抑制剂的起点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55f8/7984827/81a1264402b4/oncotarget-12-549-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55f8/7984827/467caff09d6f/oncotarget-12-549-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55f8/7984827/e4a5c003a790/oncotarget-12-549-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55f8/7984827/aac2c3e99ee4/oncotarget-12-549-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55f8/7984827/5c5f5f261145/oncotarget-12-549-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55f8/7984827/597fa5386d0e/oncotarget-12-549-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55f8/7984827/27054e7cb7da/oncotarget-12-549-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55f8/7984827/de43e2959765/oncotarget-12-549-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55f8/7984827/81a1264402b4/oncotarget-12-549-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55f8/7984827/467caff09d6f/oncotarget-12-549-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55f8/7984827/e4a5c003a790/oncotarget-12-549-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55f8/7984827/aac2c3e99ee4/oncotarget-12-549-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55f8/7984827/5c5f5f261145/oncotarget-12-549-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55f8/7984827/597fa5386d0e/oncotarget-12-549-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55f8/7984827/27054e7cb7da/oncotarget-12-549-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55f8/7984827/de43e2959765/oncotarget-12-549-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55f8/7984827/81a1264402b4/oncotarget-12-549-g008.jpg

相似文献

1
A high-content AlphaScreen™ identifies E6-specific small molecule inhibitors as potential therapeutics for HPV head and neck squamous cell carcinomas.一种高内涵AlphaScreen™技术鉴定出E6特异性小分子抑制剂可作为人乳头瘤病毒相关头颈部鳞状细胞癌的潜在治疗药物。
Oncotarget. 2021 Mar 16;12(6):549-561. doi: 10.18632/oncotarget.27908.
2
Liberation of functional p53 by proteasome inhibition in human papilloma virus-positive head and neck squamous cell carcinoma cells promotes apoptosis and cell cycle arrest.蛋白酶体抑制可使 HPV 阳性的头颈部鳞癌细胞中功能性 p53 释放,从而促进细胞凋亡和细胞周期阻滞。
Cell Cycle. 2013 Mar 15;12(6):923-34. doi: 10.4161/cc.23882. Epub 2013 Feb 19.
3
BCCIPβ facilitates p53 ubiquitination via binding with E6 protein in high-risk HPV positive head and neck squamous cell carcinoma.BCCIPβ 通过与高危型 HPV 阳性头颈部鳞状细胞癌中的 E6 蛋白结合促进 p53 的泛素化。
Biochem Biophys Res Commun. 2020 Aug 27;529(3):685-691. doi: 10.1016/j.bbrc.2020.05.183. Epub 2020 Jul 18.
4
Wild-type p53 reactivation by small-molecule Minnelide™ in human papillomavirus (HPV)-positive head and neck squamous cell carcinoma.小分子Minnelide™在人乳头瘤病毒(HPV)阳性头颈部鳞状细胞癌中对野生型p53的重新激活作用
Oral Oncol. 2014 Dec;50(12):1149-56. doi: 10.1016/j.oraloncology.2014.09.013. Epub 2014 Oct 11.
5
Targeting HPV16 E6-p300 interaction reactivates p53 and inhibits the tumorigenicity of HPV-positive head and neck squamous cell carcinoma.靶向 HPV16 E6-p300 相互作用可重新激活 p53 并抑制 HPV 阳性头颈部鳞状细胞癌的致瘤性。
Oncogene. 2014 Feb 20;33(8):1037-46. doi: 10.1038/onc.2013.25. Epub 2013 Mar 11.
6
Radioimmunotherapy of experimental head and neck squamous cell carcinoma (HNSCC) with E6-specific antibody using a novel HPV-16 positive HNSCC cell line.使用新型人乳头瘤病毒16型(HPV - 16)阳性头颈部鳞状细胞癌(HNSCC)细胞系,以E6特异性抗体对实验性头颈部鳞状细胞癌进行放射免疫治疗。
Head Neck Oncol. 2011 Feb 12;3(1):9. doi: 10.1186/1758-3284-3-9.
7
Expression of human papillomavirus oncoproteins E6 and E7 inhibits invadopodia activity but promotes cell migration in HPV-positive head and neck squamous cell carcinoma cells.人乳头瘤病毒癌蛋白 E6 和 E7 的表达抑制 HPV 阳性头颈部鳞状细胞癌细胞中的侵袭伪足活性,但促进细胞迁移。
Cancer Rep (Hoboken). 2018 Oct;1(3):e1125. doi: 10.1002/cnr2.1125. Epub 2018 Jul 27.
8
A novel small-molecule inhibitor of the human papillomavirus E6-p53 interaction that reactivates p53 function and blocks cancer cells growth.一种新型的人乳头瘤病毒 E6-p53 相互作用的小分子抑制剂,可重新激活 p53 功能并阻断癌细胞生长。
Cancer Lett. 2020 Feb 1;470:115-125. doi: 10.1016/j.canlet.2019.10.046. Epub 2019 Nov 3.
9
Bortezomib sensitises TRAIL-resistant HPV-positive head and neck cancer cells to TRAIL through a caspase-dependent, E6-independent mechanism.硼替佐米通过一种不依赖E6的半胱天冬酶依赖性机制,使对肿瘤坏死因子相关凋亡诱导配体(TRAIL)耐药的人乳头瘤病毒(HPV)阳性头颈部癌细胞对TRAIL敏感。
Cell Death Dis. 2014 Oct 23;5(10):e1489. doi: 10.1038/cddis.2014.455.
10
Molecular profile of head and neck squamous cell carcinomas bearing p16 high phenotype.头颈部鳞状细胞癌中 p16 高表型的分子谱。
Ann Oncol. 2013 Aug;24(8):2124-31. doi: 10.1093/annonc/mdt013. Epub 2013 Feb 13.

引用本文的文献

1
30-hydroxygambogic acid increases the efficacy of cisplatin in an HPV head and neck cancer in vivo model.30-羟基藤黄酸增强顺铂在人乳头瘤病毒相关头颈癌体内模型中的疗效。
BMC Cancer. 2025 Aug 1;25(1):1251. doi: 10.1186/s12885-025-14638-3.
2
Unraveling the Complex Nexus of Human Papillomavirus (HPV) in Extragenital Keratinocyte Skin Tumors: A Comprehensive Analysis of Bowen's Disease and In Situ Squamous-Cell Carcinoma.解析外生殖器角质形成细胞皮肤肿瘤中人类乳头瘤病毒(HPV)的复杂关系:鲍温病和原位鳞状细胞癌的综合分析
J Clin Med. 2024 Feb 15;13(4):1091. doi: 10.3390/jcm13041091.
3
Small Molecule Inhibitors of Human Papillomavirus: A Review of Research from 1997 to 2021.

本文引用的文献

1
The Potential of Immune Checkpoint Blockade in Cervical Cancer: Can Combinatorial Regimens Maximize Response? A Review of the Literature.免疫检查点阻断在宫颈癌中的潜力:联合治疗方案能否最大化反应?文献综述。
Curr Treat Options Oncol. 2020 Oct 6;21(12):95. doi: 10.1007/s11864-020-00790-4.
2
Clinical update on head and neck cancer: molecular biology and ongoing challenges.头颈部癌症的临床新进展:分子生物学和当前面临的挑战。
Cell Death Dis. 2019 Jul 15;10(8):540. doi: 10.1038/s41419-019-1769-9.
3
The failure of cetuximab-based de-intensified regimes for HPV-positive OPSCC: A radiobiologists perspective.
小分子人乳头瘤病毒抑制剂:1997 年至 2021 年研究综述。
Curr Med Chem. 2024;31(33):5308-5350. doi: 10.2174/0929867331666230713165407.
4
GA-OH enhances the cytotoxicity of photon and proton radiation in HPV HNSCC cells.GA-OH增强了人乳头瘤病毒相关头颈部鳞状细胞癌(HPV HNSCC)细胞对光子和质子辐射的细胞毒性。
Front Oncol. 2023 Feb 10;13:1070485. doi: 10.3389/fonc.2023.1070485. eCollection 2023.
5
ACE2 : S1 RBD Interaction-Targeted Peptides and Small Molecules as Potential COVID-19 Therapeutics.以血管紧张素转换酶2(ACE2):刺突蛋白1受体结合域(S1 RBD)相互作用为靶点的肽和小分子作为潜在的COVID-19治疗药物
Adv Pharmacol Pharm Sci. 2021 Nov 2;2021:1828792. doi: 10.1155/2021/1828792. eCollection 2021.
6
Targeted Therapy as a Potential De-Escalation Strategy in Locally Advanced HPV-Associated Oropharyngeal Cancer: A Literature Review.靶向治疗作为局部晚期人乳头瘤病毒相关口咽癌潜在的降阶梯治疗策略:文献综述
Front Oncol. 2021 Aug 17;11:730412. doi: 10.3389/fonc.2021.730412. eCollection 2021.
7
PPI Modulators of E6 as Potential Targeted Therapeutics for Cervical Cancer: Progress and Challenges in Targeting E6.作为宫颈癌潜在靶向治疗药物的E6的质子泵抑制剂调节剂:靶向E6的研究进展与挑战
Molecules. 2021 May 18;26(10):3004. doi: 10.3390/molecules26103004.
基于西妥昔单抗的减强度方案治疗人乳头瘤病毒阳性口咽鳞状细胞癌失败的原因:放射生物学家的观点
Clin Transl Radiat Oncol. 2019 May 22;17:47-50. doi: 10.1016/j.ctro.2019.05.003. eCollection 2019 Jul.
4
Quercetin induces G2 phase arrest and apoptosis with the activation of p53 in an E6 expression‑independent manner in HPV‑positive human cervical cancer‑derived cells.槲皮素通过激活 p53,以不依赖 HPV-E6 表达的方式诱导 HPV 阳性人宫颈癌源性细胞发生 G2 期阻滞和凋亡。
Mol Med Rep. 2019 Mar;19(3):2097-2106. doi: 10.3892/mmr.2019.9850. Epub 2019 Jan 11.
5
A High-Content Screen Reveals New Small-Molecule Enhancers of Ras/Mapk Signaling as Probes for Zebrafish Heart Development.高内涵筛选揭示新的小分子 Ras/MAPK 信号增强剂可作为斑马鱼心脏发育研究的探针。
Molecules. 2018 Jul 11;23(7):1691. doi: 10.3390/molecules23071691.
6
Treatment de-escalation for HPV-driven oropharyngeal cancer: Where do we stand?人乳头瘤病毒(HPV)驱动的口咽癌治疗降阶梯:我们目前的状况如何?
Clin Transl Radiat Oncol. 2017 Nov 4;8:4-11. doi: 10.1016/j.ctro.2017.10.005. eCollection 2018 Jan.
7
'Click Chemistry' Synthesis of Novel Natural Product-Like Caged Xanthones Bearing a 1,2,3-Triazole Moiety with Improved Druglike Properties as Orally Active Antitumor Agents.新型天然产物类似笼状黄烷酮的“点击化学”合成,具有改善的类药性,作为口服活性抗肿瘤药物,含有 1,2,3-三唑部分。
Molecules. 2017 Oct 27;22(11):1834. doi: 10.3390/molecules22111834.
8
NCCN Guidelines Insights: Head and Neck Cancers, Version 2.2017.NCCN 指南解读:头颈部肿瘤,第 2.2017 版。
J Natl Compr Canc Netw. 2017 Jun;15(6):761-770. doi: 10.6004/jnccn.2017.0101.
9
Human Papillomavirus Regulates HER3 Expression in Head and Neck Cancer: Implications for Targeted HER3 Therapy in HPV Patients.人乳头瘤病毒调节头颈癌中HER3的表达:对HPV患者HER3靶向治疗的意义。
Clin Cancer Res. 2017 Jun 15;23(12):3072-3083. doi: 10.1158/1078-0432.CCR-16-2203. Epub 2016 Dec 16.
10
In Vitro and In Vivo Synergistic Therapeutic Effect of Cisplatin with Human Papillomavirus16 E6/E7 CRISPR/Cas9 on Cervical Cancer Cell Line.顺铂与人乳头瘤病毒16 E6/E7 CRISPR/Cas9对宫颈癌细胞系的体内外协同治疗作用
Transl Oncol. 2016 Dec;9(6):498-504. doi: 10.1016/j.tranon.2016.10.002. Epub 2016 Oct 28.